Review Article

Screening Mammography and Digital Breast Tomosynthesis: Controversies

Authors: Kimberly Funaro, MD, Jennifer Drukteinis, MD, Shannon Falcon, MD, MS

Abstract

Breast cancer screening with mammography reduces breast cancer mortality; however, diverging recommendations regarding screening have caused controversy. The emerging technology of digital breast tomosynthesis (DBT) may soon become the mainstay of breast cancer screening. We present recommendations for breast cancer screening based on guidelines. A PubMed literature review was performed and the results from five large clinical studies comparing the efficacy of digital mammography alone versus digital mammography with DBT are examined. We emphasize the importance of annual screening to reduce breast cancer mortality. Our review of the literature demonstrates that DBT increases cancer detection rates and reduces callbacks. Additional research is needed to determine whether the increased cancer detection rates are associated with a decrease in mortality.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Howlader N, Noone AM, Krapcho M, et al, eds. SEER Cancer Statistics Review, 1975-2013. http://seer.cancer.gov/csr/1975_2013. Accessed July 25, 2017.
 
2. Smith RA, Duffy SW, Gabe R, et al. The randomized trials of breast cancer screening: what have we learned? Radiol Clin North Am 2004;42:793-806.
 
3. Kerlikowske K. Efficacy of screening mammography among women aged 40 to 49 years and 50 to 69 years: comparison of relative and absolute benefit. J Natl Cancer Inst Monogr 1997:79-86.
 
4. Bjurstam N, Björneld L, Warwick J, et al. The Gothenburg Breast Screening Trial. Cancer 2003;97:2387-2396.
 
5. Oeffinger KC, Fontham ETH, Etzioni R, et al. Breast cancer screening for women at average risk: 2015 guideline update from the American Cancer Society. JAMA 2015;314:1599-1614.
 
6. Pinsky RW, Helvie MA. Mammographic breast density: effect on imaging and breast cancer risk. J Natl Compr Canc Netw 2010;8:1157-1164.
 
7. Friedewald SM, Rafferty EA, Rose SL, et al. Breast cancer screening using tomosynthesis in combination with digital mammography. JAMA 2014;311:2499-2507.
 
8. Nelson HD, Fu R, Cantor A, et al. Effectiveness of breast cancer screening: systematic review and meta-analysis to update the 2009 U.S. Preventive Services Task Force Recommendation. Ann Intern Med 2016;164:244-255.
 
9. Saadatmand S, Bretveld R, Siesling S, et al. Influence of tumour stage at breast cancer detection on survival in modern times: population based study in 173,797 patients. BMJ 2015;351:h4901.
 
10. Kopans DB. Arguments against mammography screening continue to be based on faulty science. Oncologist 2014;19:107-112.
 
11. Tosteson AN, Fryback DG, Hammond CS, et al. Consequences of false-positive screening mammograms. JAMA Intern Med 2014;174:954-961.
 
12. Schwartz LM, Woloshin S, Fowler FJ, et al. Enthusiasm for cancer screening in the United States. JAMA 2004;291:71-78.
 
13. Mettler FA, Jr Bhargavan M, Faulkner K, et al. Radiologic and nuclear medicine studies in the United States and worldwide: frequency, radiation dose, and comparison with other radiation sources-1950-2007. Radiology 2009;253:520-531.
 
14. Physician resources. http://www.radiologyinfo.org/en/downloads. Accessed November 15, 2016.
 
15. Yaffe MJ, Mainprize JG. Risk of radiation-induced breast cancer from mammographic screening. Radiology 2011;258:98-105.
 
16. Committee on Practice Bulletins-Gynecology. Practice Bulletin Number 179: Breast cancer risk assessment and screening in average-risk women. Obstet Gynecol 2017;130:e1-e16.
 
17. Carney PA, Miglioretti DL, Yankaskas BC, et al. Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med 2003;138:168-175.
 
18. Gur D, Sumkin JH, Hardesty LA, et al. Recall and detection rates in screening mammography. Cancer 2004;100:1590-1594.
 
19. Vedantham S, Karellas A, Vijayaraghavan GR, et al. Digital breast tomosynthesis: state of the art. Radiology 2015;277:663-684.
 
20. D’Orsi CJ, Sickles EA, Mendelson EB, et al. ACR BI-RADS Atlas, Breast Imaging Reporting and Data System. Reston, VA: American College of Radiology; 2013.
 
21. Kerlikowske K, Zhu W, Hubbard RA, et al. Outcomes of screening mammography by frequency, breast density, and postmenopausal hormone therapy. JAMA Intern Med 2013;173:807-816.
 
22. Sickles EA. The use of breast imaging to screen women at high risk for cancer. Radiol Clin North Am 2010;48:859-878.
 
23. DenseBreast-info.org. Legislation and regulations-what is required? http://densebreastinfo.org/legislation.aspx. Accessed November 1, 2016.
 
24. Helvie MA. Digital mammography imaging: breast tomosynthesis and advanced applications. Radiol Clin North Am 2010;48:917-929.
 
25. Skaane P, Bandos AI, Gullien R, et al. Comparison of digital mammography alone and digital mammography plus tomosynthesis in a population-based screening program. Radiology 2013;267:47-56.
 
26. Ciatto S, Houssami N, Bernardi D, et al. Integration of 3D digital mammography with tomosynthesis for population breast-cancer screening (STORM): a prospective comparison study. Lancet Oncol 2013;14:583-589.
 
27. Rose SL, Tidwell AL, Bujnoch LJ, et al. Implementation of breast tomosynthesis in a routine screening practice: an observational study. AJR Am J Roentgenol 2013;200:1401-1408.
 
28. Haas BM, Kalra V, Geisel J, et al. Comparison of tomosynthesis plus digital mammography and digital mammography alone for breast cancer screening. Radiology 2013;269:694-700.
 
29. Lee CI, Lehman CD. Digital breast tomosynthesis and the challenges of implementing an emerging breast cancer screening technology into clinical practice. J Am Coll Radiol 2013;10:913-917.
 
30. Hunter SA, Morris C, Nelson K, et al. Digital breast tomosynthesis: cost-effectiveness of using private and Medicare insurance in community-based health care facilities. AJR Am J Roentgenol 2017;208:1171-1175.
 
31. Nelson JS, Wells JR, Baker JA, et al. How does c-view image quality compare with conventional 2D FFDM? Med Phys 2016;43:2538.
 
32. Durand MA, Haas BM, Yao X, et al. Early clinical experience with digital breast tomosynthesis for screening mammography. Radiology 2015;274: 85-92.
 
33. Gaur S, Dialani V, Slanetz PJ, et al. Architectural distortion of the breast. AJR Am J Roentgenol 2013;201:W662-W670.
 
34. Burrell HC, Sibbering DM, Wilson AR, et al. Screening interval breast cancers: mammographic features and prognostic factors. Radiology 1996;199:811-817.
 
35. Partyka L, Lourenco AP, Mainiero MB. Detection of mammographically occult architectural distortion on digital breast tomosynthesis screening: initial clinical experience. AJR Am J Roentgenol 2014;203:216-222.
 
36. Lee CI, Cevik M, Alagoz O, et al. Comparative effectiveness of combined digital mammography and tomosynthesis screening for women with dense breasts. Radiology 2015;274:772-780.
 
37. Rafferty EA, Durand MA, Conant EF, et al. Breast cancer screening using tomosynthesis and digital mammography in dense and nondense breasts. JAMA 2016;315:1784-1786.
 
38. Houssami N, Turner RM. Rapid review: estimates of incremental breast cancer detection from tomosynthesis (3D-mammography) screening in women with dense breasts. Breast 2016;30:141-145.
 
39. Mainiero MB, Lourenco A, Mahoney MC, et al. ACR appropriateness criteria breast cancer screening. J Am Coll Radiol 2013;10:11-14.
 
40. Lehman CD, Isaacs C, Schnall MD, et al. Cancer yield of mammography, MR, and US in high-risk women: prospective multi-institution breast cancer screening study. Radiology 2007;244:381-388.
 
41. Lee CH, Dershaw DD, Kopans D, et al. Breast cancer screening with imaging: recommendations from the Society of Breast Imaging and the ACR on the use of mammography, breast MRI, breast ultrasound, and other technologies for the detection of clinically occult breast cancer. J Am Coll Radiol 2010;7:18-27.
 
42. Berg WA, Blume JD, Cormack JB, et al. Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. JAMA 2008;299:2151-2163.